Global Lurasidone Hydrochloride API Market Growth 2021-2026

Global Lurasidone Hydrochloride API Market Growth 2021-2026

Product Code:157810

Published Date: Jun 09,2021

Pages: 111

Region: Global

Category: Chemical & Material

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

According to this latest study, the 2021 growth of Lurasidone Hydrochloride API will have significant change from previous year. By the most conservative estimates of global Lurasidone Hydrochloride API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Lurasidone Hydrochloride API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Lurasidone Hydrochloride API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
    Purity≥98%
    Purity<98%

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
    Lurasidone Hydrochloride Tablets
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
    Piramal Enterprises Limited
    Dr. Reddy's Laboratories
    ZCL Chemicals Limited
    Recipharm AB
    Metrochem API Private Limited
    Solara Active Pharma Sciences
    Johnson Matthey PLC
    Teva Pharmaceutical Industries Ltd.
    Hisun Pharmaceutical Nantong
    Sun Pharmaceutical Industries Ltd.
    Procos S.p.A.
    Neuland Laboratories
    Unichem Laboratories Limited
    Glenmark Pharmaceuticals
    ALP Pharm
    Lupin Ltd